These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4358643)

  • 1. TSH stimulation of 32P incorporation into phospholipids of thyroids from patients with Graves' disease.
    Schneider PB
    J Clin Endocrinol Metab; 1974 Jan; 38(1):148-50. PubMed ID: 4358643
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
    Field JB; Larsen PR; Yamashita K
    Trans Assoc Am Physicians; 1973; 86():300-9. PubMed ID: 4363386
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of TSH on iodine metabolism and intermediary metabolism in tissue from patients with Graves' disease.
    Field JB; Larsen PR; Yamashita K; Chayoth R
    J Clin Endocrinol Metab; 1974 Nov; 39(5):942-9. PubMed ID: 4370784
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine 3',5'-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglobulins in normal and Graves' thyroids.
    Kuzuya N; Uchimura H; Ikeda H; Chiu SC; Hamada N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jul; 51(1):59-63. PubMed ID: 6247365
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of thyrotropin and adenosine on inositol phospholipids pathway in human thyroid in Graves' disease.
    Zarzycki W; Mośko P; Jaroszewicz L; Kinalska I
    Biochem Biophys Res Commun; 1994 Nov; 205(1):584-9. PubMed ID: 7999083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of iodide on glucose oxidation and 32P incorporation into phospholipids stimulated by different agents in dog thyroid slices.
    Tseng FY; Rani CS; Field JB
    Endocrinology; 1989 Mar; 124(3):1450-5. PubMed ID: 2537182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin stimulation of 32P incorporation into the phospholipids of canine thyroid adenocarcinoma.
    Schneider PB; Leav I
    Endocrinology; 1977 Feb; 100(2):346-50. PubMed ID: 832628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered responsiveness to thyrotropin in thyroid slices of Graves' disease preoperatively treated with excess iodide.
    Onaya T; Miyakawa M; Makiuchi M; Furihata R
    J Clin Endocrinol Metab; 1978 Aug; 47(2):405-9. PubMed ID: 233671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of adrenergic systems in thyroid slices from patients with Graves' disease.
    Yamashita K; Aiyoshi Y; Kuzuya N; Koide Y
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):360-5. PubMed ID: 2866653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Na+ and K+ in the stimulation by thyrotropin of phospholipid turnover in bovine thyroid slices.
    Schneider PB
    Endocrinology; 1974 Dec; 95(6):1529-33. PubMed ID: 4434900
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
    Charkes ND
    J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of iodine enrichment in vitro on the adenylate cyclase-adenosine 3',5' monophosphate system in thyroid glands from normal subjects and patients with Graves' disease.
    Uchimura H; Chiu SC; Kuzaya N; Ikeda H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1066-70. PubMed ID: 6246144
    [No Abstract]   [Full Text] [Related]  

  • 16. Phospholipids of human thyroid gland.
    Stelmach H; Mośko P; Jaroszewicz L; Piotrowski Z; Puchalski Z
    Acta Physiol Hung; 1993; 81(3):263-7. PubMed ID: 8197881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the action of pituitary thyrotropin on the individual phosphatides of thyroid tissue.
    Scott TW; Jay SM; Freinkel N
    Endocrinology; 1966 Sep; 79(3):591-600. PubMed ID: 5922926
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-gamma inhibition of human thyrotropin receptor gene expression.
    Nishikawa T; Yamashita S; Namba H; Usa T; Tominaga T; Kimura H; Izumi M; Nagataki S
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1084-9. PubMed ID: 8408457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for normal thyroidal adenyl cyclase, cyclic AMP-binding and protein-kinase activities in Graves' disease.
    Orgiazzi J; Chopra IJ; Williams DE; Solomon DH
    J Clin Endocrinol Metab; 1975 Feb; 40(2):248-55. PubMed ID: 165418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.